![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 14, 2003 10:17:07 AM
Heather collins-Schramm: I am currently beginning my fifth year of the M.D./PHD program...During my first year I developed a rapid method for looking ar microsatellite allele frequency differences between populations. I then used this method to identify markers with large differences between ethnicities that should be useful for a potentially powerful genome screening methos known as Mapping by Admixture Linkage Disequilibrium (MALD).
Does that mean she developed this method four years ago, before DNAPrint Genomics came into existence?
As you noted the change from EDMs to what we know as AIMs is puzzling. Is there a reason Schramm claims to have developed the method prior to DNAP?
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM